Vista Gold (AMEX:VGZ) Azioni

Vista Gold

Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects. The company evaluate, acquire, explore and advance gold exploration and potential development projects for gold production or value adding strategic transactions. The Company has one reportable segment: Australia. The Australia segment conducts exploration, development, care and maintenance activities at Vista's asset, the Mt Todd gold project in Northern Territory, Australia.

Vista Gold Corp

Earnings

News

Vista Gold Q1 EPS $(0.02) Down From $(0.01) YoY

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates Vista Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VGZ#AMEX">VGZ</a>) with a Buy and maintains $2.75 price target.

Price Target

Reiteration

Analyst Ratings

HC Wainwright & Co. Reiterates Buy on Vista Gold, Maintains $2.75 Price Target

Vista Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VGZ#AMEX">VGZ</a>) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year.

Vista Gold Q3 EPS $(0.01), Same YoY

The price trend for Vista Gold (AMEX:VGZ) has been bearish lately and the stock has lost 5% over the past week. However, the formation of a hammer chart pattern in its last trading session indicates that the stock could witness a trend reversal soon, as bulls might have gained significant control over the price to help it find support.
The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor that makes a bullish case for the stock. On the fundamental side, strong agreement among Wall Street analysts in raising earnings estimates for this gold mining company enhances its prospects of a trend reversal.
<img alt="1-month candlestick chart for VGZ" class="chart" src="https://staticx-tuner.zacks.com/images/articles/charts/yseop/550/VGZ_Hammer.jpeg" style="height:auto; width:100%" title="" />
<h2>What is a Hammer Chart and How to Trade It?</h2>
This is one of the popular price patterns in candlestick charting. A minor difference between the opening and closing prices forms a small candle body, and a higher difference between the low of the day and the open or close forms a long lower wick (or vertical line). The length of the lower wick being at least twice the length of the real body, the candle resembles a &#39;hammer.&#39;
In simple terms, during a downtrend, with bears having absolute control, a stock usually opens lower compared to the previous day&#39;s close, and again closes lower. On the day the hammer pattern is formed, maintaining the downtrend, the stock makes a new low. However, after eventually finding support at the low of the day, some amount of buying interest emerges, pushing the stock up to close the session near or slightly above its opening price.
When it occurs at the bottom of a downtrend, this pattern signals that the bears might have lost control over the price. And, the success of bulls in stopping the price from falling further indicates a potential trend reversal.
Hammer candles can occur on any timeframe -- such as one-minute, daily, weekly -- and are utilized by both short-term as well as long-term investors.
Like every technical indicator, the hammer chart pattern has its limitations. Particularly, as the strength of a hammer depends on its placement on the chart, it should always be used in conjunction with other bullish indicators.
<h2>Here&#39;s What Makes the Trend Reversal More Likely for VGZ</h2>
An upward trend in earnings estimate revisions that VGZ has been witnessing lately can certainly be considered a bullish indicator on the fundamental side. That&#39;s because empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
Over the last 30 days, the consensus EPS estimate for the current year has increased 280%. What it means is that the sell-side analysts covering VGZ are majorly in agreement that the company will report better earnings than they predicted earlier.
If this is not enough, you should note that VGZ currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. And stocks carrying a Zacks Rank #1 or 2 usually outperform the market.
Moreover, the Zacks Rank has proven to be an excellent timing indicator, helping investors identify precisely when a company&#39;s prospects are beginning to improve. So, for the shares of Vista Gold, a Zacks Rank of 2 is a more conclusive fundamental indication of a potential turnaround.
<a href="https://www.zacks.com/stock/news/2320721/vista-gold-vgz-may-find-a-bottom-soon-here-s-why-you-should-buy-the-stock-now?cid=CS-BENZ-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2320721">To read this article on Zacks.com click here.</a>

Penny Stocks

Technicals

Small Cap

Markets

Trading Ideas

Vista Gold May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Vista Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VGZ#AMEX">VGZ</a>) reported quarterly earnings of $0.13 per share. This is a 1400 percent increase over losses of $(0.01) per share from the same period last year.

Vista Gold Q2 EPS $0.13 Up From $(0.01) YoY

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Vista Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VGZ#AMEX">VGZ</a>) with a Buy and raises the price target from $2.5 to $2.75.

HC Wainwright & Co. Maintains Buy on Vista Gold, Raises Price Target to $2.75

Vista Gold Corp. Announces Receipt Of $10M Final Instalment Payment Under Wheaton Precious Metals Royalty, In Relation To Company's Mt Todd Gold Project Located In Northern Territory, Australia

The price of gold reached all-time high of over $2,200 per ounce this week, reacting positively to the indications emerging from the latest Federal Open Market Committee (FOMC) meeting in which policymakers reiterated their intentions to cut interest rates three times <a href="https://www.benzinga.com/economics/macro-economic-events/24/03/37857035/fed-chair-powell-opens-door-to-rate-cuts-this-year-downplays-recent-inflation-upt">in the current year.</a>
The precious metal already surged by 6% this month, marking its fourth positive week out of the last five, sparking a revival in gold mining stocks.
In a recent note from Bank of America published this week, analysts reiterated gold remained one of the favored trades for 2024, citing three key drivers: its hedge status against global stocks, central banks&#8217; accumulation of gold at record levels and the potential for increased investor participation in ETF purchases.
Bank of America remarked, &#8220;More investors could enter the market if yields fall, potentially propelling the gold price to a long-term upside around $2500-$2600.&#8221;
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37879685/gold-investors-should-own-these-etfs-says-bank-of-america-why-analysts-expect-gold-">Gold Investors Should Own These ETFs, Says Bank Of America: Why Analysts Expect Gold Spike To $2,600</a>
Despite these bullish trends in gold prices, several mining stocks have trailed behind the commodity and are yet to demonstrate their full upside potential. For instance, the VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>) is down 3% year-to-date, in contrast to an 8% gain in spot gold prices.
In another note, Bank of America&#8217;s research analyst Lawson Winder, CFA, highlighted that several gold mining stocks are undervalued compared to the spot market price of gold.
According to Winder, Centerra Gold Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CGAU#NYSE">CGAU</a>) was priced as if gold were trading at $1,240 per ounce. Other undervalued mining stocks in comparison to the gold price include B2Gold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTG#NYSE">BTG</a>), Barrick Gold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>) and Newmont Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>).
&#8220;Investors should prioritize gold mining stocks that exhibit a high ratio of upside beta to downside beta, such as Barrick or Newmont,&#8221; advised Bank of America.
<h1 class="wp-block-heading">Best Performing Gold Mining Stocks In March 2024</h1>
Five gold miners have already rallied more than 30% thus far this month, showcasing a strong sensitivity to commodity price gains. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Name</td>
<td>Price Chg. % (MTD)</td>
</tr>
<tr>
<td>Gold Resource Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GORO#NYSE">GORO</a>)</td>
<td>54.12%</td>
</tr>
<tr>
<td>Austin Gold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AUST#NYSE">AUST</a>)</td>
<td>52.67%</td>
</tr>
<tr>
<td>McEwen Mining Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUX#NYSE">MUX</a>)</td>
<td>45.44%</td>
</tr>
<tr>
<td>Vista Gold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VGZ#NYSE">VGZ</a>)</td>
<td>42.58%</td>
</tr>
<tr>
<td>Coeur Mining, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>)</td>
<td>33.40%</td>
</tr>
</tbody>
</table>
</figure>
Read Now: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37881013/larry-summers-questions-feds-eagerness-to-cut-rates-as-easy-money-policies-clash-wi">Larry Summers Questions Fed&#8217;s Eagerness To Cut Rates As Easy Money Policies Clash With High Inflation: &#8216;I Don&#8217;t Fully Get It&#8217;</a>
Photo: Pixabay

Analyst Color

Sector ETFs

Commodities

Econ #s

Economics

Federal Reserve

ETFs

AUST

CGAU

Market Vectors ETF Trust Market Vectors Gold Miners

GOLD

GORO

Gold Rush Begins As Fed Hints At Rate Cuts: 5 Mining Stocks Glitter With Over 30% Rally This Month

The Dow Jones index closed higher by over 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Vista Gold </h3>
<ul>
<li>The Trade: Vista Gold Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vgz#NYSE">VGZ</a>) CFO Douglas L. Tobler <a href="https://www.benzinga.com/quote/NN/analyst-ratings"> acquired a total of 3,500 shares </a> an average price of $0.48. To acquire these shares, it cost around $1,691.</li>
<li>What&rsquo;s Happening: On March 14, Vista Gold posted a fourth-quarter loss of 1 cent per share.</li>
<li>What Vista Gold Does: Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects.</li>
</ul>
<h3>Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rvp#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 2,147 shares at </a> at an average price of $1.19. To acquire these shares, it cost around $2,555.</li>
<li>What&rsquo;s Happening: On Nov. 14, Retractable Technologies reported that its loss from operations was $8.7 million for the first nine months of 2023.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/24/03/37868715/top-3-tech-and-telecom-stocks-that-are-ticking-portfolio-bombs"> Top 3 Tech And Telecom Stocks That Are Ticking Portfolio Bombs </a>
<h3>Fresh Tracks Therapeutics </h3>
<ul>
<li>The Trade: Fresh Tracks Therapeutics, Inc. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/frtx#OTC">FRTX</a>) 10% owner Exploration Capital, LLC <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 297 shares </a> at an average price of $0.91. The insider spent around $270 to buy those shares.</li>
<li>What&rsquo;s Happening: The company&rsquo;s stock fell around 6% over the past six months.</li>
<li>What Fresh Tracks Therapeutics Does: Fresh Tracks Therapeutics Inc does not have any operations as it has discontinued its activities.</li>
</ul>
&nbsp;
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
&nbsp;

Long Ideas

Insider Trades

Pre-Market Outlook

FRTX

Vista Gold And 2 Other Stocks Under $2 Insiders Are Buying

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates Vista Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VGZ#AMEX">VGZ</a>) with a Buy and maintains $2.5 price target.

HC Wainwright & Co. Reiterates Buy on Vista Gold, Maintains $2.5 Price Target

Vista Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VGZ#AMEX">VGZ</a>) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year.

&nbsp;
Summary of Quarterly Results
&nbsp;
<table>
<tbody>
<tr>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
</tr>
<tr>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td colspan="2">
4th&nbsp;quarter
</td>
<td>
&nbsp;
</td>
<td colspan="2">
3rd&nbsp;quarter
</td>
<td>
&nbsp;
</td>
<td colspan="2">
2nd&nbsp;quarter
</td>
<td>
&nbsp;
</td>
<td colspan="2">
1st&nbsp;quarter
</td>
<td>
&nbsp;
</td>
</tr>
<tr>
<td>
2023
</td>
<td>
&nbsp;&nbsp;&nbsp;&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;&nbsp;&nbsp;&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;&nbsp;&nbsp;&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;&nbsp;&nbsp;&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
</tr>
<tr>
<td>
Revenue
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
&mdash;
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
&mdash;
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
&mdash;
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
&mdash;
</td>
<td>
&nbsp;
</td>
</tr>
<tr>
<td>
Net income/(loss)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(1,657)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(1,454)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(1,503)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(1,971)
</td>
<td>
&nbsp;
</td>
</tr>
<tr>
<td>
Basic income/(loss) per share
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(0.01)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(0.01)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(0.01)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(0.02)
</td>
<td>
&nbsp;
</td>
</tr>
<tr>
<td>
2022
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
<td>
&nbsp;
</td>
</tr>
<tr>
<td>
Revenue
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
&mdash;
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
&mdash;
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
&mdash;
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
&mdash;
</td>
<td>
&nbsp;
</td>
</tr>
<tr>
<td>
Net income/(loss)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(1,495)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(1,692)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(1,424)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(320)
</td>
<td>
&nbsp;
</td>
</tr>
<tr>
<td>
Basic income/(loss) per share
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(0.01)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(0.02)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(0.01)
</td>
<td>
&nbsp;
</td>
<td>
$
</td>
<td>
(0.00)
</td>
<td>
&nbsp;
</td>
</tr>
</tbody>
</table>
&nbsp;

Vista Gold Q4 EPS $(0.01), Same YoY

Precious metals surged once again in response to Fed Chair Jerome Powell&#8216;s recent statements hinting at potential monetary policy easing in 2024, contingent upon further positive data on inflation and growing confidence that price pressures will align <a href="https://www.benzinga.com/markets/equities/24/03/37511027/jerome-powell-hints-at-2024-interest-rate-cuts-awaits-greater-confidence-on-inflation-stocks-reb">with the 2% target.</a>
Gold prices, as gauged by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), soared 0.8% to $2,150/oz during midday trading in New York, surpassing the previous peak of $2,146/oz set in December 2023. The yellow metal is now on track for its seventh consecutive day of gains.
Similarly, silver experienced a notable 2.2% rally, reaching $24.20/oz, its highest level since the end of December 2023. Since the beginning of the month, both gold and silver have seen impressive gains of 5% and 6.4%, respectively.
Treasury yields extended their decline on Wednesday, with the 10-year yield falling to 4.1%, marking its lowest level in a month. Similarly, longer-dated 30-year yields dropped by 5 basis points to 4.25%, the lowest since early February.
The U.S. dollar index (DXY), as tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), fell by 0.5%, on track for its worst session in 2024. 
In response to queries regarding the timing of potential Fed rate cuts, Powell remarked, &#8220;We are not expecting inflation to necessarily hit the 2% mark, but we do require further evidence.&#8221; Powell emphasized the anticipation of a continued decline in 12-month inflation readings. 
The Fed Chair dismantled fears of an imminent recession and stated that commercial real estate risks are &#8216;manageable.&#8217;
Markets reflect expectations of four rate cuts by December 2024, with a 73% probability assigned to the first rate cut potentially occurring as early as June.
<h2 class="wp-block-heading">Chart: Gold Prices Reach Record Highs</h2>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/06132325/image-11-1024x495.png" alt="" class="wp-image-241808" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/06132325/image-11-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/06132325/image-11-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/06132325/image-11-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/06132325/image-11-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/06132325/image-11.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">Mining Stocks Rally Wednesday</h2>
The significant upticks in both gold and silver sparked a vigorous rally among mining stocks on Wednesday.
The VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>) rose 2.5%, poised for a fifth straight days of gains, reaching the highest since mid-January. 
The VanEck Junior Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDXJ#NYSE">GDXJ</a>) surged 2.4%, showing a similar trend. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Name</td>
<td>1-Day %</td>
<td>Market Cap</td>
</tr>
<tr>
<td>Ivanhoe Electric Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IE#NYSE">IE</a>)</td>
<td>12.03%</td>
<td>$ 1.05B</td>
</tr>
<tr>
<td>Contango Ore, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTGO#NYSE">CTGO</a>)</td>
<td>8.63%</td>
<td>$ 186.97M</td>
</tr>
<tr>
<td>Vista Gold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VGZ#NYSE">VGZ</a>)</td>
<td>7.27%</td>
<td>$ 53.25M</td>
</tr>
<tr>
<td>Coeur Mining, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>)</td>
<td>6.19%</td>
<td>$ 1.19B</td>
</tr>
<tr>
<td>Austin Gold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AUST#NYSE">AUST</a>)</td>
<td>5.73%</td>
<td>$ 13.15M</td>
</tr>
<tr>
<td>DRDGOLD Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRD#NYSE">DRD</a>)</td>
<td>4.88%</td>
<td>$ 684.89M</td>
</tr>
<tr>
<td>Gold Resource Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GORO#NYSE">GORO</a>)</td>
<td>4.70%</td>
<td>$ 24.48м</td>
</tr>
<tr>
<td>Hycroft Mining Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYMC#NASDAQ">HYMC</a>)</td>
<td>3.7%</td>
<td>$ 41.31M</td>
</tr>
<tr>
<td>Freeport-McMoRan Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>)</td>
<td>3.61%</td>
<td>$ 55.17B</td>
</tr>
<tr>
<td>Hecla Mining Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>)</td>
<td>3.40%</td>
<td>$ 2.43B</td>
</tr>
</tbody>
</table>
</figure>
Read now: <a href="https://www.benzinga.com/markets/equities/24/03/37490089/exclusive-truemark-investment-ceo-reveals-strategy-to-beat-markets-with-actively-managed-etfs">EXCLUSIVE: TrueMark Investment CEO Reveals Strategy To Beat Markets With Actively Managed ETFs</a>
Photo via Shutterstock.

Equities

Broad U.S. Equity ETFs

Specialty ETFs

Currency ETFs

CRML

CTGO

GDXJ

Hycroft Mining Holding Corporation - Class A Common Stock

HYMC

PowerShares DB US Dollar Index Bullish Fund

Gold Hits All-Time Highs, Silver Rallies To 2024 Peak As Powell Hints At Fed Rate Cuts: 10 Mining Stocks Moving Wednesday

The Dow Jones index closed slightly higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Entera Bio </h3>
<ul>
<li>The Trade: Entera Bio Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/entx#NASDAQ">ENTX</a>) Director Haya Taitel <a href="https://www.benzinga.com/quote/ENTX/analyst-ratings"> acquired a total of 7,615 shares </a> an average price of $0.77. To acquire these shares, it cost around $5,86.</li>
<li>What&rsquo;s Happening: Entera Bio announced that it received an extension of 180 calendar days from the Nasdaq stock market to regain compliance.</li>
<li>What Entera Bio Does: Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins.</li>
</ul>
<h3>OPKO Health</h3>
<ul>
<li>The Trade: OPKO Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opk#NASDAQ">OPK</a>) 10% owner Frost Gamma Investments Trust <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 511,531 shares at </a> at an average price of $0.94. To acquire these shares, it cost around $480,379.</li>
<li>What&rsquo;s Happening: OPKO Health recently priced private offering of $200 million convertible senior notes due 2029.</li>
<li>What OPKO Health Does: OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/01/36606238/citigroup-bank-of-america-and-3-stocks-to-watch-heading-into-friday"> Citigroup, Bank of America And 3 Stocks To Watch Heading Into Friday</a>
<h3>Fresh Tracks Therapeutics </h3>
<ul>
<li>The Trade: Fresh Tracks Therapeutics, Inc. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/frtx#OTC">FRTX</a>) 10% owner Exploration Capital LLC <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 51,502 shares </a> at an average price of $0.98. The insider spent around $50,472 to buy those shares.</li>
<li>What&rsquo;s Happening: Fresh Tracks Therapeutics plans to hold new special meeting of stockholders on Feb. 15, 2024 to seek stockholder approval of liquidation.</li>
<li>What Fresh Tracks Therapeutics Does: Fresh Tracks Therapeutics Inc is a clinical-stage pharmaceutical company striving to transform patient lives through the development of innovative and differentiated prescription therapeutics.</li>
</ul>
<h3>Vista Gold </h3>
<ul>
<li>The Trade: Vista Gold Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vgz#NYSE">VGZ</a>) Director Tracy Austin Stevenson<a href="https://www.benzinga.com/quote/VGZ/analyst-ratings"> acquired a total of 20,000 shares</a> at an average price of $0.37. The insider spent around $7,324 to buy those shares.</li>
<li>What&rsquo;s Happening: Vista Gold recently announced it will receive $20 million from Wheaton Precious Metals as part of a royalty agreement in relation to the company&#39;s Mt Todd gold project.</li>
<li>What Vista Gold Does: Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects.</li>
</ul>

Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

ENTX

Entera Bio And 3 Other Stocks Under $1 Insiders Are Buying

The Dow Jones index closed higher by over 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Vivani Medical </h3>
<ul>
<li>The Trade: Vivani Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vani#NASDAQ">VANI</a>) Director Gregg Williams <a href="https://www.benzinga.com/quote/VANI/analyst-ratings"> acquired a total of 153,872 shares </a> an average price of $0.88. To acquire these shares, it cost around $135,403.</li>
<li>What&rsquo;s Happening: Vivani Medical, last month, posted a wider-than-expected quarterly loss.</li>
<li>What Vivani Medical Does: Vivani Medical Inc is a preclinical stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases.</li>
</ul>
<h3>Amesite</h3>
<ul>
<li>The Trade: Amesite Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amst#NASDAQ">AMST</a>) CEO Ann Marie Sastry <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 10,000 shares </a> at an average price of $1.85. To acquire these shares, it cost around $18,500.</li>
<li>What&rsquo;s Happening: Amesite recently announced a five-year partnership with West Virginia Northern Community College.</li>
<li>What Amesite Does: Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high performance and scalable online products for schools and businesses.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/23/12/36337879/how-to-earn-500-a-month-from-broadcom-stock-following-recent-rally"> How To Earn $500 A Month From Broadcom Stock Following Recent Rally </a>
<h3>Vista Gold </h3>
<ul>
<li>The Trade: Vista Gold Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vgz#NYSE">VGZ</a>) CFO Douglas L Tobler <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 3,500 shares </a> at an average price of $0.45. The insider spent around $1,558 to buy those shares.</li>
<li>What&rsquo;s Happening: Vista Gold recently announced it will receive $20 million from Wheaton Precious Metals as part of a royalty agreement in relation to the company&#39;s Mt Todd gold project.</li>
<li>What Vista Gold Does: Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects.</li>
</ul>
<h3>BigBear.ai Holdings </h3>
<ul>
<li>The Trade: BigBear.ai Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbai#NYSE">BBAI</a>) Director Pamela Braden <a href="https://www.benzinga.com/quote/BBAI/analyst-ratings"> acquired a total of 50,025 shares </a> at an average price of $1.92. The insider spent around $96,048 to buy those shares.</li>
<li>What&rsquo;s Happening: BigBear.Ai recently announced an expanded partnership with Amazon.com Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>) Web Services to deliver AI-driven solutions.</li>
<li>What BigBear.ai Holdings Does: BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers.</li>
</ul>
&nbsp;
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

AMST

AMZN

BBAI

VANI

BigBear.ai And 3 Other Stocks Under $3 Insiders Are Buying

Vista Gold Corp. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/VGZ#TSX">VGZ</a>) (&quot;Vista&quot; or the &quot;Company&quot;) is pleased to announce that its wholly-owned subsidiary, Vista Gold Australia Pty. Ltd. (&quot;Vista Australia&quot;) has received the first installment payment of&nbsp;$3 million&nbsp;(&quot;First Installment&quot;) under the royalty agreement between Vista Australia and Wheaton Precious Metals (Cayman) Co., an affiliate of Wheaton Precious Metals Corp. (&quot;Wheaton&quot;) dated December 13, 2023 (&quot;Royalty Agreement&quot;), in relation to the Company&#39;s Mt Todd gold project (&quot;Mt Todd&quot; or the &quot;Project&quot;) located in Northern Territory, Australia. All dollar amounts in this news release are in US dollars.
The First Installment is part of the&nbsp;$20 million&nbsp;royalty with Wheaton, which will be used to advance Mt Todd and for general corporate purposes. The remaining two installment payments are expected in the first half of 2024 and are subject to approval from the Australian government Foreign Investment Review Board. The principal terms of the Royalty Agreement are as described in the Company&#39;s news release dated December 14, 2023. See&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fvistagold.com%2Fnews%2Fnews-2023%2F788-vista-gold-corp-announces-20-million-royalty-with-wheaton-precious-metals-corp-on-mt-todd&amp;esheet=53872030&amp;newsitemid=20231216433416&amp;lan=en-US&amp;anchor=News+Release&amp;index=1&amp;md5=8a943c84849deb9565e4198d9661ffb7">News Release</a>.

TSX:VGZ

Vista Gold Corp Secures $3M from Wheaton for Mt Todd Project, Advancing with $20M Royalty Deal

WIIM

Vista Gold shares are trading higher after the company announced it will receive $20 million from Wheaton Precious Metals as part of a royalty agreement in relation to the company's Mt Todd gold project.

Shares of Amtech Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asys#NASDAQ">ASYS</a>) shares fell sharply during Thursday&rsquo;s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.
Amtech reported quarterly sales of $27.70 million, missing the analyst consensus estimate of $34.50 million. The company anticipated first-quarter revenue to be between $21 million and $24 million, versus the $34.15 million estimate.
Benchmark analyst Mark Miller downgraded Amtech Systems from Buy to Hold.
Amtech Systems shares fell 30.6% to $4.16 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Freight Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frgt#NASDAQ">FRGT</a>) shares jumped 322% to $1.14 after the company announced Amazon Mexico renewed its selection of Fr8App for its logistical solutions.</li>
<li>SRIVARU Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svmh#NASDAQ">SVMH</a>) rose 74.8% to $0.7000.</li>
<li>XBP Europe Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xbp#NASDAQ">XBP</a>) shares gained 49% to $8.46 after declining around 20% on Wednesday.</li>
<li>TPI Composites, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpic#NASDAQ">TPIC</a>) rose 46% to $3.1350 as the company announced refinancing transaction with Oaktree, significantly strengthening company&rsquo;s liquidity position and enhancing financial flexibility.</li>
<li>Nxu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxu#NASDAQ">NXU</a>) rose 43.6% to $0.0280 after the company signed a letter of intent outlining investment in Lynx Motors.</li>
<li>Canterbury Park Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cphc#NASDAQ">CPHC</a>) rose 31% to $18.70.</li>
<li>View, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/view#NASDAQ">VIEW</a>) gained 29% to $5.14.</li>
<li>Hanryu Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hryu#NASDAQ">HRYU</a>) gained 27.1% to $1.3850 after jumping 28% on Wednesday.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/espr#NASDAQ">ESPR</a>) shares climbed 23.2% to $1.8603. Esperion said that the FDA updated LDL-C lowering indication for NEXLETOL (bempedoic acid) tablet and NEXLIZET (bempedoic acid and ezetimibe) tablet.</li>
<li>Redfin Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdfn#NASDAQ">RDFN</a>) gained 21.8% to $10.26.</li>
<li>Codexis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdxs#NASDAQ">CDXS</a>) shares surged 20.5% to $2.5184. Codexis announced achievement of gram-scale synthesis with its ECO Synthesis platform.</li>
<li>Vista Gold Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vgz#NYSE">VGZ</a>) gained 20% to $0.4010. Vista Gold announced a $20 million royalty with Wheaton Precious Metals Corp. on Mt Todd.</li>
<li>Altice USA, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atus#NYSE">ATUS</a>) rose 18.8% to $2.4950.</li>
<li>Sunnova Energy International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nova#NYSE">NOVA</a>) gained 18.3% to $14.09.</li>
<li>Wayfair Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/w#NYSE">W</a>) rose 17.3% to $66.75.</li>
<li>Sunrun Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/run#NASDAQ">RUN</a>) gained 16.7% to $17.42.</li>
<li>Blend Labs, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blnd#NYSE">BLND</a>) surged 16.7% to $2.1950. Blend Labs Head of Finance and Admin. Amir Jafari acquired a total of 12,610 shares at an average price of $1.22.</li>
<li>Moderna, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) rose 15.8% to $91.14. Moderna and Merck &amp; Co announced follow-up data from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study of mRNA-4157 (V940), an investigational individualized neoantigen therapy (INT), in combination with Keytruda in patients with resected high-risk melanoma (stage III/IV) following complete resection.</li>
<li>VCI Global Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vcig#NASDAQ">VCIG</a>) gained 15.4% to $2.62 after its financial technology arm, Accuventures Sdn Bhd, agreed to acquire the Malaysian digital platform EVOLET.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pacb#NASDAQ">PACB</a>) surged 14.2% to $10.12. Stephens &amp; Co. initiated coverage on Pacific Biosciences with an Overweight rating and announced a price target of $11.</li>
<li>Alector, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alec#NASDAQ">ALEC</a>) rose 14.8% to $7.92. Stifel upgraded Alector from Hold to Buy and raised the price target from $8 to $15.</li>
<li>Opendoor Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/open#NASDAQ">OPEN</a>) gained 14.4% to $4.71.</li>
<li>Enphase Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/enph#NASDAQ">ENPH</a>) rose 13.6% to $122.22.</li>
<li>Plug Power Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plug#NASDAQ">PLUG</a>) gained 12.7% to $4.8550.</li>
<li>Alcoa Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aa#NYSE">AA</a>) gained 11% to $28.84. Alcoa received approval for continued mining in Western Australia.</li>
<li>RH (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rh#NYSE">RH</a>) gained 7.3% to $304.60.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Reneo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rphm#NASDAQ">RPHM</a>) shares dipped 87.3% to $0.9861. Reneo Pharmaceuticals said its pivotal STRIDE study of mavodelpar in adult patients with primary mitochondrial myopathies did not meet its primary efficacy or secondary efficacy endpoint.</li>
<li>Mynd.ai, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mynd#NYSE">MYND</a>) fell 53.1% to $2.71.</li>
<li>Cepton, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cptn#NASDAQ">CPTN</a>) fell 24.2% to $3.01 after the company posted downbeat third-quarter sales and issued weak FY23 revenue forecast. Craig-Hallum downgraded Cepton from Buy to Hold.</li>
<li>Apellis Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apls#NASDAQ">APLS</a>) declined 20.7% to $49.81 after the company announced it was informed of a negative trend vote on the marketing authorization application for pegcetacoplan.</li>
<li>NextCure, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtc#NASDAQ">NXTC</a>) fell 20.7% to $1.15 after the company issued year-end clinical pipeline updates.</li>
<li>MIND Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mind#NASDAQ">MIND</a>) dipped 19.4% to $4.7414 following weak quarterly results.</li>
<li>Aditxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adtx#NASDAQ">ADTX</a>) fell 16.4% to $5.26.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) shares fell 15.1% to $3.3450. Ocular Therapeutix priced its public offering of 30.8 million common share stock at $3.25 per share for gross proceeds of $100.1 million.</li>
<li>NextPlay Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtp#NASDAQ">NXTP</a>) shares fell 11.4% to $1.3905 after jumping 68% on Wednesday.</li>
<li>Regis Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rgs#NYSE">RGS</a>) shares fell 9.9% to $8.39. NYSE will begin delisting proceedings against Regis Corp.</li>
<li>ABM Industries Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abm#NYSE">ABM</a>) dipped 9.5% to $47.33. ABM recently reported better-than-expected fourth-quarter financial results and issued guidance.</li>
<li>Intensity Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ints#NASDAQ">INTS</a>) shares fell 9.4% to $8.94 after jumping 22% on Wednesday. Intensity Therapeutics recently named Joseph Talamo as CFO.</li>
<li>AerSale Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asle#NASDAQ">ASLE</a>) shares fell 8% to $13.60. AerSale priced its secondary offering of 4 million common shares.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) fell 7.6% to $19.95.</li>
<li>Adobe Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adbe#NASDAQ">ADBE</a>) fell 6.2% to $585.55. Adobe posted upbeat earnings for its fourth quarter, but issued weak sales forecast for full-year 2024.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/12/36231379/wait-for-a-pullback-youre-late-to-the-party-jim-cramer-says-about-this-tech-stock"> &#39;Wait For A Pullback &mdash; You&#39;re Late To The Party&#39;: Jim Cramer Says About This Tech Stock</a>

Intraday Update

Movers

ADBE

ADTX

ALEC

APLS

ASLE

ASYS

ATUS

BLND

CDXS

CPHC

CPTN

ENPH

ESPR

FRGT

HRYU

INTS

MIND

MRNA

MYND

NOVA

NXTC

NXTP

OCUL

OPEN

PACB

PLUG

RDFN

RILY

RPHM

SVMH

TPIC

VCIG

VIEW

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Press Releases

Vista Gold 2024 Drilling Demonstrated Potential to Increase Mt Todd Mineral Reserves

Vista Gold 2025 Initiatives Pave the Way for Value Realization at Mt Todd

Vista Gold to Participate in the Prospectors & Developers Association of Canada 2025 Convention

Vista Gold Corp. Announces 2024 Financial Results

Vista Gold Publishes 2024 Environmental, Social and Governance Report

Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now

Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now

Vista Gold to Present at the Mining Forum Europe 2025 Conference

Vista Gold Announces Voting Results from Annual General and Special Meeting of Shareholders

Comments

Vista Gold

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO